| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Respiratory Medicine, Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, UK.
Correspondence to: Robert A. Stockley, MD, DSc, Department of Medicine, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK
Study objectives: To stratify COPD patients presenting with an acute exacerbation on the basis of sputum color and to relate this to the isolation and viable numbers of bacteria recovered on culture.
Design: Open, longitudinal study of sputum characteristics and acute-phase proteins.
Setting: Patients presenting to primary-care physicians in the United Kingdom. Patients were followed up as outpatients in specialist clinic.
Patients: One hundred twenty-one patients with acute exacerbations of COPD were assessed together with a single sputum sample on the day of presentation (89 of whom produced a satisfactory sputum sample for analysis). One hundred nine patients were assessed 2 months later when they had returned to their stable clinical state.
Interventions: The expectoration of green, purulent sputum was taken as the primary indication for antibiotic therapy, whereas white or clear sputum was not considered representative of a bacterial episode and the need for antibiotic therapy.
Results: A positive bacterial culture was obtained from 84% of patients sputum if it was purulent on presentation compared with only 38% if it was mucoid (p < 0.0001). When restudied in the stable clinical state, the incidence of a positive bacterial culture was similar for both groups (38% and 41%, respectively). C-reactive protein concentrations were significantly raised (p < 0.0001) if the sputum was purulent (median, 4.5 mg/L; interquartile range [IQR], 6.2 to 35.8). In the stable clinical state, sputum color improved significantly in the group who presented with purulent sputum from a median color number of 4.0 (IQR, 4.0 to 5.0) to 3.0 (IQR, 2.0 to 4.0; p < 0.0001), and this was associated with a fall in median C-reactive protein level to 2.7 mg/L (IQR, 1.0 to 6.6; p < 0.0001).
Conclusions: The presence of green (purulent) sputum was 94.4% sensitive and 77.0% specific for the yield of a high bacterial load and indicates a clear subset of patient episodes identified at presentation that is likely to benefit most from antibiotic therapy. All patients who produced white (mucoid) sputum during the acute exacerbation improved without antibiotic therapy, and sputum characteristics remained the same even when the patients had returned to their stable clinical state.
Key Words: bacteria • COPD • exacerbations • myeloperoxidase • sputum
This article has been cited by other articles:
|
|
 |
|
  B. R. Celli Update on the Management of COPD Chest, June 1, 2008; 133(6): 1451 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Vijayasaratha and R. A. Stockley Reported and Unreported Exacerbations of COPD: Analysis by Diary Cards Chest, January 1, 2008; 133(1): 34 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Jones and A. G. N. Agusti Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur. Respir. J., April 1, 2006; 27(4): 822 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Sapey and R A Stockley COPD exacerbations {middle dot} 2: Aetiology. Thorax, March 1, 2006; 61(3): 250 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G C Donaldson and J A Wedzicha COPD exacerbations {middle dot} 1: Epidemiology Thorax, February 1, 2006; 61(2): 164 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Woodhead, F. Blasi, S. Ewig, G. Huchon, M. Leven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, and T. J. M. Verheij Guidelines for the management of adult lower respiratory tract infections Eur. Respir. J., December 1, 2005; 26(6): 1138 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Barnes and R. A. Stockley COPD: current therapeutic interventions and future approaches Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lode, J. Eller, A. Linnhoff, M. Ioanas, and the Evaluation of Therapy-Free Interval in COPD Pa Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval Eur. Respir. J., December 1, 2004; 24(6): 947 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J R Hurst and J A Wedzicha Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation Postgrad. Med. J., September 1, 2004; 80(947): 497 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Pauwels Similarities and Differences in Asthma and Chronic Obstructive Pulmonary Disease Exacerbations Proceedings of the ATS, April 1, 2004; 1(2): 73 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Miravitlles and A. Torres No More Equivalence Trials for Antibiotics in Exacerbations of COPD, Please Chest, March 1, 2004; 125(3): 811 - 813. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sethi, C. Wrona, B. J. B. Grant, and T. F. Murphy Strain-specific Immune Response to Haemophilus influenzae in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., February 15, 2004; 169(4): 448 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.C. Donaldson, T.A.R. Seemungal, I.S. Patel, S.J. Lloyd-Owen, T.M.A. Wilkinson, and J.A. Wedzicha Longitudinal changes in the nature, severity and frequency of COPD exacerbations Eur. Respir. J., December 1, 2003; 22(6): 931 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. A. Wilkinson, I. S. Patel, M. Wilks, G. C. Donaldson, and J. A. Wedzicha Airway Bacterial Load and FEV1 Decline in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1090 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W A Biernacki, S A Kharitonov, and P J Barnes Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD Thorax, April 1, 2003; 58(4): 294 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Walter, A. Beiser, R. J. Givelber, G. T. O'Connor, and D. J. Gottlieb Association between Glycemic State and Lung Function: The Framingham Heart Study Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 911 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A J White, S Gompertz, and R A Stockley Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease Thorax, January 1, 2003; 58(1): 73 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I S Patel, T A R Seemungal, M Wilks, S J Lloyd-Owen, G C Donaldson, and J A Wedzicha Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations Thorax, September 1, 2002; 57(9): 759 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Miravitlles Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur. Respir. J., July 1, 2002; 20(36_suppl): 9S - 19s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sohy, C. Pilette, M.S. Niederman, and Y. Sibille Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Eur. Respir. J., May 1, 2002; 19(5): 966 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Wedzicha Exacerbations* : Etiology and Pathophysiologic Mechanisms Chest, May 1, 2002; 121(5_suppl): 136S - 141S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Stockley Neutrophils and the Pathogenesis of COPD* Chest, May 1, 2002; 121(5_suppl): 151S - 155S. [Full Text] [PDF]
|
|
|
|
|
|
T. F. Murphy, S. Sethi, S. L. Hill, and R. A. Stockley INFLAMMATORY MARKERS IN BACTERIAL EXACERBATIONS OF COPD Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 132 - 132. [Full Text] [PDF]
|
|
|
|
|
|
I S Woolhouse, S L Hill, and R A Stockley Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis Thorax, December 1, 2001; 56(12): 947 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Wedzicha Airway Infection Accelerates Decline of Lung Function in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1757 - 1758. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Stockley, S. Sethi, and T. F. Murphy Inflammation and Acute Exacerbations of Chronic Bronchitis Chest, October 1, 2001; 120(4): 1422 - 1423. [Full Text] [PDF]
|
|
|
|
|
|
M. Miravitlles, C. Murio, and T. Guerrero Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis Eur. Respir. J., May 1, 2001; 17(5): 928 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R A Stockley, D Bayley, S L Hill, A T Hill, S Crooks, and E J Campbell Assessment of airway neutrophils by sputum colour: correlation with airways inflammation Thorax, May 1, 2001; 56(5): 366 - 372. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Sethi and T. F. Murphy Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review Clin. Microbiol. Rev., April 1, 2001; 14(2): 336 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. PAUWELS, A. S. BUIST, P. M. A. CALVERLEY, C. R. JENKINS, and S. S. HURD Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease . NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1256 - 1276. [Full Text]
|
|
|
|
 |
|
 Green Sputum in COPD Indicates High Bacterial Load Journal Watch Emergency Medicine, July 18, 2000; 2000(718): 7 - 7. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
